Literature DB >> 19571235

Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.

Srinivasan Dasarathy1, Takhar Kasumov, John M Edmison, Lourdes L Gruca, Carole Bennett, Clarita Duenas, Susan Marczewski, Arthur J McCullough, Richard W Hanson, Satish C Kalhan.   

Abstract

The rates of oxidation of glycine and ureagenesis were quantified in the basal state and in response to an intravenous infusion of intralipid with heparin (IL) in healthy subjects (n = 8) and in subjects with nonalcoholic steatohepatitis (NASH) (n = 6). During fasting, no significant difference in weight-specific rate of appearance (R(a)) of glycine, glycine oxidation, and urea synthesis was observed. Intralipid infusion resulted in a significant increase in plasma beta-hydroxybutyrate in both groups. The correlation between free fatty acids and beta-hydroxybutyrate concentration in plasma was 0.94 in NASH compared with 0.4 in controls, indicating greater hepatic fatty acid oxidation in NASH. Intralipid infusion resulted in a significant decrease in urea synthesis and glycine R(a) in both groups and did not impact glycine oxidation. The fractional contribution of glycine carbon to serine was lower in subjects with NASH before and after IL infusion. In contrast, the fractional contribution of serine carbon to cystathionine was higher in NASH before and following IL infusion. These results suggest that hepatic fatty acid oxidation is higher in NASH compared with controls and that glycine oxidation and urea synthesis are not altered. An increase in oxidative stress, induced by a higher rate of fatty acid oxidation in NASH, may have caused an increase in the contribution of serine to cystathionine to meet the higher demands for glutathione.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19571235      PMCID: PMC2739817          DOI: 10.1152/ajpgi.00042.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  51 in total

Review 1.  The glycine story.

Authors:  A A Jackson
Journal:  Eur J Clin Nutr       Date:  1991-02       Impact factor: 4.016

Review 2.  Mitochondrial dysfunction in hepatitis C virus infection.

Authors:  C Piccoli; R Scrima; A D'Aprile; M Ripoli; L Lecce; D Boffoli; N Capitanio
Journal:  Biochim Biophys Acta       Date:  2006-05-19

3.  Total body metabolism of 13C-octanoic acid is preserved in patients with non-alcoholic steatohepatitis, but differs between women and men.

Authors:  Arne R J Schneider; Christine Kraut; Birgit Lindenthal; Barbara Braden; Wolfgang F Caspary; Jürgen Stein
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-11       Impact factor: 2.566

4.  Glycine production in severe childhood undernutrition.

Authors:  Farook Jahoor; Asha Badaloo; Marvin Reid; Terrence Forrester
Journal:  Am J Clin Nutr       Date:  2006-07       Impact factor: 7.045

Review 5.  Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

Authors:  Janardan K Reddy; M Sambasiva Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05       Impact factor: 4.052

Review 6.  Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.

Authors:  Michael W Bradbury
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-02       Impact factor: 4.052

7.  Relation between transamination of branched-chain amino acids and urea synthesis: evidence from human pregnancy.

Authors:  S C Kalhan; K Q Rossi; L L Gruca; D M Super; S M Savin
Journal:  Am J Physiol       Date:  1998-09

8.  Nitrogen homeostasis in man: influence of protein intake on the amplitude of diurnal cycling of body nitrogen.

Authors:  G M Price; D Halliday; P J Pacy; M R Quevedo; D J Millward
Journal:  Clin Sci (Lond)       Date:  1994-01       Impact factor: 6.124

Review 9.  Liver disease in mitochondrial disorders.

Authors:  Way S Lee; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2007-08       Impact factor: 6.115

10.  Reciprocal changes in gluconeogenesis and ureagenesis induced by fatty acid oxidation.

Authors:  A Martín-Requero; G Ciprés; T Rivas; M S Ayuso; R Parrilla
Journal:  Metabolism       Date:  1993-12       Impact factor: 8.694

View more
  17 in total

1.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

2.  Whole body creatine and protein kinetics in healthy men and women: effects of creatine and amino acid supplementation.

Authors:  Satish C Kalhan; Lourdes Gruca; Susan Marczewski; Carole Bennett; China Kummitha
Journal:  Amino Acids       Date:  2015-10-19       Impact factor: 3.520

3.  Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine.

Authors:  Satish C Kalhan; John Edmison; Susan Marczewski; Srinivasan Dasarathy; Lourdes L Gruca; Carole Bennett; Clarita Duenas; Rocio Lopez
Journal:  Clin Sci (Lond)       Date:  2011-08       Impact factor: 6.124

4.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

5.  Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.

Authors:  Kwangwon Lee; Andrew Haddad; Abdullah Osme; Chunki Kim; Ahmad Borzou; Sergei Ilchenko; Daniela Allende; Srinivasan Dasarathy; Arthur McCullough; Rovshan G Sadygov; Takhar Kasumov
Journal:  Mol Cell Proteomics       Date:  2018-08-31       Impact factor: 5.911

Review 6.  Stable isotope-based flux studies in nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen Previs; Takhar Kasumov
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

7.  HDL flux is higher in patients with nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen F Previs; Jaividhya Dasarathy; Kwangwon Lee; Abdullah Osme; Chunki Kim; Serguei Ilchenko; Shuhui W Lorkowski; Jonathan D Smith; Srinivasan Dasarathy; Takhar Kasumov
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-09-10       Impact factor: 4.310

Review 8.  Resurgence of serine: an often neglected but indispensable amino Acid.

Authors:  Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2012-05-07       Impact factor: 5.157

9.  Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.

Authors:  Jorge Simon; Maitane Nuñez-García; Pablo Fernández-Tussy; Lucía Barbier-Torres; David Fernández-Ramos; Beatriz Gómez-Santos; Xabier Buqué; Fernando Lopitz-Otsoa; Naroa Goikoetxea-Usandizaga; Marina Serrano-Macia; Rubén Rodriguez-Agudo; Maider Bizkarguenaga; Imanol Zubiete-Franco; Virginia Gutiérrez-de Juan; Diana Cabrera; Cristina Alonso; Paula Iruzubieta; Manuel Romero-Gomez; Sebastiaan van Liempd; Azucena Castro; Ruben Nogueiras; Marta Varela-Rey; Juan Manuel Falcón-Pérez; Erica Villa; Javier Crespo; Shelly C Lu; Jose M Mato; Patricia Aspichueta; Teresa C Delgado; María Luz Martínez-Chantar
Journal:  Cell Metab       Date:  2020-02-21       Impact factor: 27.287

10.  Is the adiponectin-AMPK-mitochondrial axis involved in progression of nonalcoholic fatty liver disease?

Authors:  Srinivasan Dasarathy
Journal:  Hepatology       Date:  2014-05-06       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.